Aeon Astron Europe B.V.   Report issue

For profit Phase 2 Phase 4
Founded: Leiden Netherlands (2008)
Status: Acquired by Body Organ Biomedical Corporation (2008)

Organization Overview

First Clinical Trial
2009
NCT01174420
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Aeon Astron Europe B.V. | AEON Biopharma, Inc. | Aeon Biotechnology Corporation | OculusGen Biomedical Inc.